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ABSTRACT
The xeroderma pigmentosum group D (XPD) helicase
is a component of the transcription factor IIH com-
plex in eukaryotes and plays an essential role in DNA
repair in the nucleotide excision repair pathway. XPD
is a 5′ to 3′ helicase with an essential iron–sulfur
cluster. Structural and biochemical studies of the
monomeric archaeal XPD homologues have aided a
mechanistic understanding of this important class
of helicase, but several important questions remain
open. In particular, the mechanism for DNA loading,
which is assumed to require large protein confor-
mational change, is not fully understood. Here, DNA
binding by the archaeal XPD helicase from Thermo-
plasma acidophilum has been investigated using a
combination of crystallography, cross-linking, mod-
ified substrates and biochemical assays. The data
are consistent with an initial tight binding of ssDNA
to helicase domain 2, followed by transient opening
of the interface between the Arch and 4FeS domains,
allowing access to a second binding site on helicase
domain 1 that directs DNA through the pore. A crys-
tal structure of XPD from Sulfolobus acidocaldiarius
that lacks helicase domain 2 has an otherwise unper-
turbed structure, emphasizing the stability of the in-
terface between the Arch and 4FeS domains in XPD.
INTRODUCTION
XPD (xeroderma pigmentosum group D) is a 5′-3′ super-
family 2 (SF2) helicase (1) that unwinds damaged DNA
during the process of nucleotide excision repair (NER). In
eukaryotes, XPD is one of the components of transcription
factor IIH (TFIIH) along with nine other protein subunits
(2–6). The major enzymatic function of XPD is to unwind
the DNA double helix around lesions such as photoprod-
ucts to allow repair (7). XPD acts as a structural bridge
between the core subunits and the Cdk-activating kinase
(CAK) complex (6,8). While TFIIH is essential for both
transcription initiation and NER, the adenosine triphos-
phate (ATP)-dependent helicase activity of XPD is only re-
quired for repair (5,9,10). In humans, XPDmutations result
in three related diseases: xeroderma pigmentosum (XP), tri-
chothiodystrophy and combined XP with Cockayne’s syn-
drome (XP/CS) (11).
The monomeric archaeal homologues of XPD have
proven amenable to study, with four apo crystal structures
(PDB IDs: 2vsf; 3crv; 3crw; and 2vl7) reported (12–14). Ar-
chaeal XPD is comprised of four domains: two RecA-like
domains that form the motor core (HD1 and HD2) and
two auxiliary domains (4FeS domain and Arch domain)
that are inserted into HD1. The 4FeS domain is stabilized
by a 4Fe-4S cluster that is essential for the helicase activ-
ity (15) and is conserved in a family of eukaryotic SF2B
helicases (15). This cluster was suggested to have a role in
charge transfer (CT) via DNA, which could be involved
in lesion recognition and conformational control (16–18).
The Arch, 4FeS and HD1 domains form a central ‘pore’
that is largely closed in the crystal structures (Figure 1A)
and the presumed helicase mechanism of XPD involves the
passage of the translocated strand through this ‘pore’ (12–
14,19,20). However, in the case of Sulfolobus acidocaldarius
XPD (SaXPD) the ‘pore’ does not actually exist when the
molecule is viewed as a surface, rather a pore appears only in
cartoon representations (Figure 1B). The in vivo function of
XPD requires binding to nucleotides within a repair bubble,
thus XPD would have to undergo a conformational change
separating the Arch and 4FeS domains to create a pore as
these domains are tightly packed in SaXPD (Figure 1B) and
Thermoplasma acidophilum XPD (TaXPD) (a small pore)
(Figure 1A).
To date, there is only one reported crystal structure of
a XPD–DNA complex (PDB ID: 4a15) (19) and although
an oligonucleotide 22-nt long was used for crystallization,
only 4 nt were located, bound in a cleft in HD2.Mutational
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Figure 1. Crystal structures of XPD. (A) Cartoon representation of apo
TaXPD (lightblue) (PDB ID: 2vsf) and TaXPD (density)––DNA (yel-
low) (PDB ID: 4a15). Both structures show the Arch domain in contact
with the 4FeS domain resulting in closed conformation. (B) The surface
representation of apo SaXPD shows that this homologue has practically
no pore in the closed conformation. (C) Crystal structure of the cova-
lent TaXPD–DNA complex showing each domain coloured differently:
HD1––salmon, 4FeS––green, Arch––deepteal and HD2––grey. The 4Fe-
4S cluster is shown as orange–yellow spheres in all structures.
analysis suggested that the binding site of the translocated
strand extended between the HD1 and 4FeS domains (19).
The mechanism of XPD helicase activity remains unclear
with uncertainties about the binding of the 3′-end of the
translocated DNA strand, the positioning of the junction
between single- and double-stranded DNA and the role of
protein conformational change in unwinding the DNA. In
a recent study, the opening of the pore was monitored by at-
taching a Cy3 fluorophore to a cysteine mutant in the Arch
domain of Ferroplasma acidarmanus XPD (FaXPD) and
measuring the quenching by the 4Fe-4S cluster in a single
molecule system (21). FaXPD was found to undergo tran-
sitions between the closed state and what was proposed to
be an open state, both in the presence and absence of DNA.
DNAwas not observed to have any effect on the position of
the equilibrium and the lifetime of the closed conformation
was 3-fold longer than that of the open one. The apparent
stability of the closed structure is consistent with the crys-
tal structures, which are all closed––Figure 1A and B. The
majority (70%) of DNA binding events were initiated in the
closed conformation, suggesting that initial binding is not
dependent on pore opening.
Here, we present a new TaXPD–DNA complex, obtained
by covalently linking the 5′-end of the DNA to the pro-
tein through an alkanethiol moiety. We have experimentally
identified further interactions betweenDNA and conserved
residues of the protein. We demonstrate that DNA loading
by TaXPD does not involve threading of DNA and that
covalently linking the Arch domain to the 4FeS domain
inhibits helicase activities without affecting the affinity of
TaXPD for DNA. We propose a model for TaXPD loading
onto and unwinding of DNA.
MATERIALS AND METHODS
TaXPD expression, purification and site directed mutagene-
sis
A synthetic gene of TaXPD, in which the three native cys-
teines that are not ligated to the iron cluster were mu-
tated to alanine, was designed and purchased (DNA2.0,
USA). The gene was supplied in the pJexpress401 vec-
tor with kanamycin resistance and a Tobacco Etch Virus
(TEV)-cleavable N-terminal 6-histidine tag for affinity pu-
rification was included. This ‘no cysteine’ gene, in essence a
new ‘native’, and subsequent mutants were transformed in
Escherichia coli Rosetta cells (the sequences of mutagenic
oligos are available from the corresponding author on re-
quest). For the crystallization experiments, a gene coding
for a shorter construct (20–615), previously used for the apo
structure (14) and that ismissing theQ-motif, wasmore suc-
cessful in obtaining good diffracting crystals. The missing
Q-motif results in an enzyme that is less active as a heli-
case. However, since its ‘truncated’ constructs bind DNA
with the same affinity as full length and recognizes ssDNA
in the same manner as in the full length version study (19),
we conclude it is a useful guide. All biological assays em-
ployed full-length protein.
The cells were grown in LB medium supplemented with
35 !g/ml kanamycin at 37◦C. When OD600nm reached 0.8–
1, the temperature was lowered to 28◦C and the protein ex-
pression was induced with 0.25 mM IPTG overnight. The
cells were harvested (15 000× g, 15 min, 4◦C), resuspended
and lysed by sonication in ice-cooled lysis buffer (20 mM
Tris-HCl pH 7.5, 500 mM NaCl, 10 mM imidazole and
one ethylenediaminetetraacetic acid (EDTA)-free protease-
inhibitor tablet), followed by centrifugation at 40 000× g at
4◦C for 40 min. After passage through a 0.45 !m filter, the
supernatant was loaded on a Ni-column equilibrated with
the lysis buffer and the column was washed with buffer A
(20 mM Tris-HCl pH 7.5, 500 mM NaCl, 30 mM imida-
zole) until the absorption reached the baseline. The proteins
were eluted with an imidazole gradient running from 30 to
500 mM, with TaXPD generally eluting at around 170 mM
imidazole. The fractions containing the protein were iden-
tified by sodium dodecyl sulphate-polyacrylamide gel elec-
trophoresis (SDS-PAGE), pooled and dialysed for 2 h in 20
mM Tris-HCl pH 7.5, 500 mM NaCl, 1 mM Dithiothre-
itol (DTT). The His-tag was cleaved overnight by adding
0.1× w/w TEV protease in fresh buffer. Next day, the pro-
tein was loaded again on a Ni-column equilibrated with the
lysis buffer without the protease inhibitor tablet andwashed
with the same buffer until the absorption reached the base-
line. The cleaved protein, which does not bind to the col-
umn, was collected in the flow-through. The protein was
concentrated down to 4–5 ml and loaded on a gel filtration
column HiLoad 26/60 Superdex 200 column (GE Health-
care) equilibrated with gel-filtration (GF) buffer (20 mM
Tris-HCl pH 7.5 or pH 8.2 (the E542C mutant), 200 mM
NaCl). The protein-containing fractions were verified for
purity by SDS-PAGE and the pure fractions were pooled
and concentrated.
Formation of the apo TaXPD–DNA crosslinked complex
Approximately 20–30 !M TaXPD E542C was incubated
overnight at 4◦C with a 2-fold excess of an alkanethiol
5′-modified DNA (IDT) in 20 mM Tris-HCl pH 8.3–8.5
+ 50 mM NaCl, in the absence or presence of 1 mM
AMPPNP/MgCl2. The buffer was degassed and purged
with nitrogen and the tube was sealed with parafilm in an
anaerobic glovebox under nitrogen, to reduce the oxygen
level. The DNA sequence was 5′-HO-(CH2)6-S-S-(CH2)6-
TACGACGGCCAGTGC-3′ for the 15mer. ShorterDNA
lengths (9, 10, 11 and 13 nt––obtained by removing nu-
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cleotides from the 3′-end of the sequence above) and also
one hairpin DNA (5′-HO-(CH2)6-S-S-(CH2)6-TAC GAG
AGA GAG AGA ACC GAG CAT TTG CTC G-3′) were
also used.Next, the samplewas subjected to anion exchange
chromatography using a MonoQ 5/50 GL column (Amer-
shamBiosciences) eluted with aNaCl gradient from 50mM
to 1 M concentration. The free protein eluted at around
250 mM NaCl, the TaXPD–DNA complex at around 400
mM NaCl (the 13mer DNA) and the free DNA eluted at
around 700 mMNaCl. The fractions were analysed by non-
reducing SDS-PAGE. The fractions that eluted in the main
peak of the complex were pulled together and concentrated
to A280 ∼8. The sample was further diluted 1:1 with 20 mM
Tris-HCl pH 8 to reduce the NaCl concentration to ∼200
mM for crystallization. The integrity of the complex was
checked by mass spectrometry.
Crystallization, data collection and structure analysis of the
TaXPD–13mer DNA complex
The crosslinked complex was crystallized in an anaerobic
glovebox under nitrogen at room temperature (RT). Crys-
tals were obtained with sitting-drop vapour diffusion in
drops containing equal volumes (1 + 1 !l) of the protein–
DNA covalent complex and a reservoir solution contain-
ing 0.2 M KCl, 0.1 M Mg-Acetate × 4H2O, 0.05 M Na-
cacodylate × 3H2O pH 6.5, 10% PEG8k (condition C2 of
Natrix screen,HamptonResearch). Prior to data collection,
the crystal was soaked in a cryoprotecting solution con-
sisting of the mother liquor supplemented with 2% PEG8k
and 30% glycerol, mounted in a loop and immediately flash
cooled in liquid nitrogen. Diffraction data were collected at
Diamond Light Source, UK, beamline I24 at a wavelength
of 0.9686 A˚ and beamsize 50 × 50 !m. In total 600 diffrac-
tion images were collected with 0.2◦ oscillation and 0.2 s
exposure/image. The images were indexed and integrated
with iMosflm (22,23), and scaled and merged with AIM-
LESS (24) to a 2.2 A˚ resolution. Molecular replacement
with the PDB ID: 4a15 without the DNA and the 4Fe-4S
cluster was used to phase the crystal structurewith Phaser in
CCP4 (25). The crystal belongs to space group P65 with unit
cell dimensions a = b = 78.6 A˚ and c = 177.8 A˚. Refmac5
in CCP4 (26,27) was used for refinement. The parameters
and statistics are shown in Table 1.
Intra-molecular crosslinking of Arch to 4FeS domain
Cysteine pairs 100C-238C and 107C-238C were introduced
into the TaXPD protein to enable chemical crosslinking
between the Arch and 4FeS domains. Approximately 30
!M TaXPD 100C-238C or 107C-312C was first incu-
bated for ∼20 min with a 3× molar excess of Tris-(2-
carboxyethyl)phosphine (TCEP) in order to reduce the cys-
teines. The excess of TCEP was removed with a PD10 or
a PG25 desalting column (depending on the volume) equi-
librated with GF buffer (pH 7.5). The protein concentra-
tion in each fraction was checked measuring the absorp-
tion at 280 nm with a nanodrop. Next, the protein was in-
cubated in an anaerobic glovebox with 3–4 sequential ad-
ditions of 0.5 × BM(PEG)3 (Thermo Scientific, Supple-
mentary Scheme S1) excess, each subjected to ∼1 h incu-
bation. A total of 10 mM "-mercaptoethanol was added
to inhibit unreacted crosslinker and these chemicals were
removed by passage over a PD10/PG25 desalting column
equilibrated with gel filtration buffer (pH 7.5). Crosslink-
ing efficiency was evaluated using a combination of mass
spectrometry, 5, 5′-dithiobis-2-nitrobenzoic acid (DTNB or
Ellman’s reagent) assay and SDS-PAGE. The DTNB assay
measures free thiol and thus reports the unreacted thiol that
remains after crosslinking. The ‘no cysteine’ native TaXPD
was used as control and its readings subtracted from the cys-
teine mutants. Extended overnight incubation followed by
another hour incubation with 0.5× excess crosslinker im-
proved crosslinking for 100–238C, but not 107–312C.
DNA binding assay
The affinity between DNA and TaXPD was measured by
fluorescence anisotropy with a Cary Eclipse fluorescence
spectrophotometer (Varian) using excitation at 490 nm and
emission at 520 nm. The pathlength was 1 cm; the emis-
sion and excitation slit widths were each 10 nm. Before pro-
tein titration, 100 nM hairpin DNA labelled with fluores-
cein at 3′-end (5′-TAC GAC AGA GAA GAG ACG AGC
ATT TTT GCT CGG AAG GA-3′-Fl) was equilibrated in
120!l buffer (20mM2-(N-morpholino)ethanesulfonic acid
(MES) pH 6.4, 1 mMDTT and 1mMMgCl2). The binding
was monitored in the presence and absence of 1 mM non-
hydrozable ATP analogue, AMPPNP. The protein stocks
contained the same concentration of DNA to avoid its dilu-
tion. Anisotropy and total fluorescence intensity were mea-
sured in parallel after ∼2 min. equilibration following each
protein addition and the effects of dilution on protein con-
centration were corrected. ‘Magic angle’ conditions were
used in order to minimize rotational effects on fluorescence
intensity. Data were fitted with the 1:1 binding quadratic
equation, which is derived for total concentrations of reac-
tants:
A= Amin + (Amax − Amin)×(
100+x+Kd+
√
(100+x+Kd)2−4×100×x
)
2×100
where, A––anisotropy; Amin––minimum anisotropy
(anisotropy of free DNA); Amax––maximum anisotropy
(anisotropy of the TaXPD–DNA complex); x––total
protein concentration; Kd–– the dissociation constant.
ATPase assay
Adenosine triphosphatase (ATPase) activity was assayed
with BIOMOL green reagent (28,29). The assay was per-
formed in 20 mMMES pH 6.4 with the final volume 50 !l
and a ssDNA with the sequence 5′-CGT CGA GGA ATT
CAA CCA CCG CTC TTC TCA ACT GCA GTC TAG
ACTCGAGC-3′ was used. TheDNA and TaXPD concen-
trations were 25 and 50 nM, respectively. ATP and MgCl2
were added first to the plate followed by the protein–DNA
mixture. The BIOMOL green reagent was added at differ-
ent time points and the absorbance at 620 nm was recorded
with a Multiskan FC (Thermo Scientific) after 5 min. incu-
bation. Each ATPase assay was performed in triplicate and
each measurement was accompanied by a standard curve
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Table 1. Crystallographic data collection and statistics of TaXPD-13mer and SaXPD
Parameter TaXPD-13mer PDB ID: 5H8W SaXPD (truncated) PDB ID: 5H8C
Data collection
Space group P65 P212121
Wavelength (A˚) 0.9686 0.9686
Cell dimensions
a, b, c (A˚) 78.6, 78.6, 177.8 64.80, 77.8, 99.5
#, ", $ (deg) 90, 90, 120 90, 90, 90
Resolution (A˚) 37.22–2.20 (2.27–2.20) 29.91–2.29 (2.35–2.29)
Total reflections 124929 110072
Unique reflections 31168 23154
Completeness (%) 99 (99.7) 99.6 (99.8)
Rmerge 8.8 (67.9) 3.3 (69.3)
<I/%I> 10.1 (2.4) 18.2 (2.3)
Redundancy 4.0 (4.0) 4.8 (4.9)
Refinement
Resolution (A˚) 37.22–2.20 29.91–2.29
Rcryst/Rfree (%) 20.8/24.3 20.3/23.9
No. of atoms
Protein/ions/DNA/FeS 4805/2/85/8 2750/0/0/8
Water 43 7
Residual B factors (A˚2)
Protein/DNA 43/53 80/-
Water/ions 33/35 64/-
Rmsd Bond lengths (A˚) 0.009 0.010
Rmsd Bond angles (o) 1.47 1.68
Ramach’n favoured (%) 98 96.1
using the provided phosphate sample. The ATPase activity
of the Walker A mutant (K35A) was also investigated as a
control.
Helicase assay
The helicase activity was investigated using a fluorescence-
based helicase assay and an open fork DNA adapted from
a previous study (19). The DNA had a dabcyl modification
on the 3′-end of the translocated strand (5′- AGCTACCAT
GCC TGC ACG AAT TAA GCA ATT CGT AAT CAT
GGT CAT AGC T-3′-dabcyl) and a Cy3 label at the 5′-end
of the opposite strand (Cy3–5′-AGC TAT GAC CATGAT
TAC GAA TTG CTT GGA ATC CTG ACG AAC TGT
AG-3′). The oligonucleotides were purchased from IDT.
The underlined parts form the duplex. In the duplex, dabcyl
resided in close vicinity to and was quenched by Cy3. This
quenching is removed upon unwinding byTaXPD.The sub-
strate having the 5′-end of the translocated strand modi-
fied with biotin± neutravidin was also tested. The oligonu-
cleotides were annealed at a molar ratio of 1:1 (final con-
centration 40 !M each) in annealing buffer (10 mM Tris-
HCl pH 7.5, 50 mM NaCl) by slowly cooling the sample
overnight after 5 min incubation at 95◦C in a water bath.
The DNA was next run on a native 12% acrylamide:TBE
gel. The visible fluorescent band was excised and cut in
small pieces and slowly shaken overnight at 4◦C in anneal-
ing buffer. The DNA solution was separated from the gel
pieces with amicro bio-spin column (Bio-rad) and theDNA
concentrationwasmeasured from the absorbance at 260 nm
using the extinction coefficient 150 000 l mole−1 cm−1. The
final concentration of the DNA substrate in the assay was
50 nM. Excess concentrations of TaXPD over DNA were
necessary for efficient helicase activity. Assays were carried
out in a Cary Eclipse fluorescence spectrophotometer (Var-
ian), at 20◦C in 20 mM MES pH 6.4 and in the presence
of 0.1 mg/ml bovine serum albumin, 1 mM MgCl2 and 1
mM ATP, with a final total volume of 150 !l. All compo-
nents except ATP were mixed and incubated together at RT
for 10 min; ATP (15!l of 10 mM inMES buffer) was added
and incubated in the cuvette for the same period of time and
the reaction was started by adding the mixed components
in the cuvette. As a control, the inactive TaXPD Walker A
mutation (K35A) was measured. For 100C-238C, the de-
pendence on the degree of crosslinking was also tested.
Expression, purification and crystallization of S. acidocal-
darius XPD (SaXPD)
The xpd gene from S. acidocaldarius (1–551) cloned into the
pET28c vector (Rudolf, 2006) was cut with BamHI/NcoI
restriction enzymes and recloned into previously designed
pEHISTEV vector (30) with kanamycin resistance. The
three native cysteines that do not coordinate the 4Fe-4S
cluster––C360, C523 and C543 were mutated to serine.
SaXPD was expressed as an N-terminally 6His-tagged pro-
tein in E. coliC43 cells. The cells were grown in LBmedium
supplemented with 35 !g/ml kanamycin at 37◦C. When
OD600nm reached 0.8–1, the temperature was lowered to
28◦C and the protein expression was induced with 0.2 mM
IPTG overnight. The purification was similar to TaXPD,
the GF buffer having pH 7.5.
For crystallization, the protein was mixed with 1.4-fold
excess of a 16T oligo having a fluorescein attached to the
T8 nucleotide in 20 mM Tris pH 7.5, 100 mMNaCl, 1 mM
MgCl2, 1 mM TCEP. The mixture was incubated at RT in
an anaerobic glovebox under nitrogen for 1 h. Crystals were
obtained with sitting-drop vapour diffusion in drops con-
taining equal volumes (1 + 1 !l) of the protein–DNA com-
plex and a reservoir solution containing 0.1 M Hepes pH
7.5, 5% isopropanol and 10% PEG4k (condition 41 from
Crystal Screen Lite, Hampton Research). The crystals took
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Figure 2. (A) Anion exchange (AE) purification of TaXPD E542C–13mer
covalent complex. The peak corresponding to fraction C1 contains the apo
TaXPD; the peak corresponding to D12 and the one between E8 and E10
are the elution of the covalent complex and apo DNA, respectively (see
panel B). The grey line represents the gradient of buffer B. (B) SDS-PAGE
with samples corresponding to themain peaks of the AE purification;MW
is themolecularmarker andAE corresponds to the sample loaded onto the
MonoQ column. One can see the shift in mass between the apo protein and
the complex (best seen between fractions C1 and C10).
an unexpectedly long time of ∼3 months to grow. Prior to
data collection, the crystal was soaked in a cryoprotecting
solution consisting of the mother liquor supplemented with
5% isopropanol, 2% PEG4k and 25% glycerol, mounted
in a loop and immediately flash cooled in liquid nitrogen.
Diffraction data were collected at Diamond Light Source,
UK, beamline I24 at a wavelength of 0.9686 A˚. 900 im-
ages of 0.15◦ oscillations were indexed, integrated, scaled
and merged to a 2.3 A˚ resolution with the automated xia2
data-processing suite (31–36) available at Diamond. Three
ensembles consisting of HD1 (10–81, 149–192 and 304–
353), 4FeS (82–148) and Arch domain (193–303), respec-
tively, were used to phase the crystal structure with Phaser
in CCP4 (25). The crystal belongs to space group P212121
with unit cell dimensions of a= 64.8 A˚, b= 77.8 A˚ and c=
99.5 A˚. Refmac5 in CCP4 (26,27) was used for refinement.
The parameters and statistics are shown in Table 1.
RESULTS
TaXPD–DNA covalent complex
Initial attempts to obtain crystals of an XPD–DNA com-
plex, with protein from three archaeal species (Sulfolobus
tokodaii,S. acidocaldarius andThermoplasma acidophilium)
and different DNA sequences with or without a fluorescein
modification yielded the native protein structure. Therefore,
we decided to covalently crosslink the DNA to the pro-
tein through disulphide trapping, inspired by previous work
(37–41) although we used the alkanethiol moiety at the 5′
end of DNA. Based on the available structure of a TaXPD–
DNA complex (19), we inserted a E542C mutation in the
new ’no cysteine’ native protein to form an intermolecu-
lar disulphide between TaXPD and alkanethiol-modified
oligonucleotide DNA (Supplementary Figure S1). Our pre-
diction was that the crosslinker would be flexible enough
to allow the DNA to adopt the conformation seen previ-
ously at the 5′ end and by anchoring the DNA we would
disclose the 3′ binding region. The crosslinking reaction
was efficient, with more than 80% of protein-modified co-
valent complex (Figure 2 and Supplementary Figure S2).
Similar results were obtained for ssDNA of length varying
Figure 3. Fo-Fc map of DNA contoured at 3 % after refinement of the pro-
tein structure; the DNA structure is modelled into the electronic density.
from 9 (Supplementary Figure S3A) to 15 nt as well as a
hairpin DNA (Supplementary Figure S4). This crosslink-
ing method has the advantage that the oligonucleotides can
be synthesized commercially.
Good diffracting crystals of all complexes tested were ob-
tained only in the presence ofMg2+ and after longer periods
of time (weeks) compared with the protein in the absence
of covalently linked DNA or in the presence of unmodified
DNA (days). All crystal structures showed electron density
truncated around 4–5 nt. Mass spectrometry revealed upon
overnight incubation with MgCl2 (required for crystalliza-
tion) that DNA was cleaved to shorter forms (Supplemen-
tary Figure S3B). Higher MgCl2 concentrations (10 mM)
resulted in a TaXPD-7mer when AMPPNP was present
and a TaXPD-5mer when it was not (Supplementary Fig-
ure S3C). The TaXPD–DNA complex was preserved in the
presence of AMPPNP and MgCl2 when using a 3′-hairpin
DNA (Supplementary Figure S4C). We attribute the cleav-
age to very low levels of a contaminating nuclease activity
and to the 3′ end of the DNA being mobile.
The highest quality structure was obtained from a crys-
tal of the TaXPD–13mer covalent complex diffracting to
2.2 A˚ resolution. Unambiguous unbiased electron density
was observed for the 4 nt (TACG) from the 5′- end of the
DNA after refinement of the protein (Figure 3). The den-
sity improved after modelling each nucleotide into the den-
sity. Additionally, some density for the––(CH)6––linker and
weak density of the fifth nucleotide (adenosine) that can-
not be clearly interpreted appeared after refinement of the
first four nucleotides (Supplementary Figure S5). The over-
all conformation of TaXPD is similar to the previous struc-
ture of a TaXPD–DNA complex, PDB ID: 4a15 (19), with
theArch domain in contact to the 4FeS domain (Figures 1C
and 4A). This suggests that the crosslink does not disrupt
the canonical DNA binding interface. Three nucleotides
approximately overlap with the previous structure (Figure
4A), but the N position corresponds to the N + 1 position
from the 5′ end in the previous structure (19). Therefore,
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Figure 4. (A) Covalent TaXPD–DNA (grey: TaXPD, cyan: DNA) in comparison with previous TaXPD–DNA complex structure, PDB ID: 4a15 (density:
TaXPD, yellow: DNA). (B) Closeup view of the covalently crosslinked DNA (cyan) to TaXPD (grey) in comparison with the previous DNA conformation
(yellow). The positions of nucleotides relative to TaXPD corresponding to PDB ID: 4a15 are shown in brackets. The nucleotide in position 2 (T) is shifted
upwards compared with the corresponding nucleotide (A) in PDB ID: 4a15. (C) Preserved interactions in the covalent complex (D582–R584–phosphate
polar contacts and DNA base (A) stacked between F538 and P530); same colour code as in (B). (D) New structural information derived from the covalent
complex, not reported previously: the loop 422–428 changes its conformation compared with the apo structure (PDB ID: 2vsf) as Y425 interacts with the
cytosine base; the guanine base is stabilized by R529 and E354 and the phosphate through hydrogen bonds with the NH- of Y458, a water molecule and
possibly R477; lightblue: the apo TaXPD; grey and cyan: TaXPD and DNA in the covalent complex, respectively. (E) Crystal structure of SaXPD with
the HD2 domain proteolytically cleaved (palegreen) in comparison to full-length SaXPD, PDB ID: 3crv (red: HD1, 4FeS, Arch and grey: HD2); (F) Front
side of SaXPD, HD2 (the cleaved domain) is not shown for clarity; (G) ∼180◦ rotation of Figure 4E showing comparison of SaXPD full-length and the
cleaved protein.
our fourth nucleotide (guanine) occupies the fifth position
not seen before (Figure 4B), disclosing new interactions. For
clarity, the nucleotides’ positions in the PDB ID: 4a15 in-
stead of the numbers will be used henceforth.
The nucleotide in position 2 from the 5′-end is shifted in
our structure relative to the previous structure (19) presum-
ably as a result of the crosslink (Figure 4B). Interactions re-
ported previously (19) are preserved in our structure (Figure
4C): the N&1 and N&2 atoms of R584 stabilize the phos-
phate of cytosine in position 4 (previously guanine), D582
forms hydrogen bonds with R584 stabilizing it in the proper
position for DNA binding, and the adenine base in position
3 (previously cytosine) is stacked between F538 and P530.
The Y425 residue in the loop 422–428 that could not be
resolved in the previous complex interacts with the cytosine
base from position 4. The loop undergoes a conformational
change relative to the apo protein, which positions Y425 in
a suitable conformation to stack against the cytosine base
(Figure 4D). The nucleotide (G) corresponding to the fifth
unresolved position in the previous complex structure is sta-
bilized by the side chain of R529 stacking against the gua-
nine base that also forms hydrogen bonds with E354 (Fig-
ure 4D). The phosphate in the sixth position is stabilized
by polar interactions with the––NH of Y458 through a wa-
ter molecule and probably by R477. Y458 is strictly con-
served among several organisms (Y542 in humanXPD) and
Y542C is one of the mutants that cause the XP disease in
humans.
Crystal structure of a proteolytic fragment of SaXPD sug-
gests rigidity in the HD1-Arch-4FeS substructure
The crystal structure of SaXPD, obtained from crystals that
grew after an unexpectedly long (3 months) time, revealed
the absence of the HD2 domain, which most probably was
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Figure 5. Biochemical data of intra-molecular crosslinked TaXPD (schematically represented above) in comparison to non-crosslinked TaXPD. (A) Fluo-
rescence anisotropy data of DNA-binding in the absence (left) and presence (right) of 1 mMAMPPNP and the best-fit binding curves: 107–312 NC (black
triangles), 107–312 83%C (red rhombs), 100–238NC (yellow circles), 100–238 90%C (green squares). (B) ATPase assay of crosslinked and non-crosslinked
TaXPD; left: 107–312 NC (blue), 107–312 83% C (cyan) and walker A mutant (K35A) (black); right: 100–238 NC (blue) and 100–238 90% C (cyan). (C)
Time courses of DNA unwinding by intra-molecular crosslinked and non-crosslinked TaXPD 107C-312C (left) and 100C-238C (right). The walker A
mutant (K35A) is also shown for comparison. A schematic representation of the substrate used in the helicase assays is shown above. The additional
biotin-neutravidin modification on the 5′- overhang is modelled by arrows. NC: non-crosslinked, C: crosslinked. The percent of crosslinked TaXPD is also
indicated.
proteolytically cleaved. Interestingly, the rest of the domains
maintained the closed conformation (Figure 4E–G), with
the Arch domain being only slightly shifted compared to
the full-length protein, probably due to lost interactions be-
tween theArch domain andHD2domain. The crystal pack-
ing positioned the Arch domain from a symmetric molecule
in place of the missing HD2 domain.
The role of the pore
The DNA–protein crystallization experiments suggested to
us that ssDNA engages HD2 but is weakly (if at all) rec-
ognized by HD1 and this allows its facile degradation by
contaminating nuclease(s). The current accepted model for
DNA unwinding has DNA in contact with HD1. To exper-
imentally establish the route of DNA, the Arch domain was
covalently crosslinked to the 4FeS domain with BM(PEG)3
(1, 8-bis (maleimido) diethylene glycol, Scheme S1) to form
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Figure 6. Representation of possible XPD–DNA conformational states.
Initially, HD2 domain grabs the 5′-end of the DNA (shown in cyan), pro-
tecting it against nuclease degradation. The 3′-end of DNA is dynamic,
prone to nuclease cleavage and might shuttle between in and out of the
pore. The Arch–4FeS interface needs to get disrupted transiently for the
DNA to pass through the pore during DNA translocation.
a permanently closed enzyme (Supplementary Figure S6A
and B). Two double cysteine mutants were designed and
crosslinked: E107C (4FeS domain)––E312C (Arch domain)
and D100C (4FeS domain)––R238C (Arch domain) with
the distances between the C" of the cysteines 12 and 12.9
A˚, respectively (Supplementary Figure S6C and D, respec-
tively). Following crosslinking with BM(PEG)3, the percent
of crosslinked cysteines was deduced from measurement of
remaining free cysteines using a DTNB assay (Supplemen-
tary Figure S7A). A total of 17% of the cysteines of 107C-
312C and 8% of 100C-238C remained unmodified (Supple-
mentary Table S1) implying that the crosslinked protein was
83 and 92% of the total concentration, respectively. SDS-
PAGE (Supplementary Figure S7B) shows that only a small
amount of protein was crosslinked inter-molecularly and
mass spectrometry confirmed monomeric TaXPD + one
molecule of crosslinker as the dominant species (Supple-
mentary Figure S8).
These modified enzymes were assessed for DNA bind-
ing, ATPase and helicase activity (Figure 5A, B and C, re-
spectively). The DNA binding affinities of the crosslinked
species were not significantly different from the non-
crosslinked controls (Figure 5A, Table 2), however DNA-
stimulated ATPase activity of TaXPD was reduced by 2–3-
fold (Figure 5B, Table 2). Helicase activity increased with
the protein concentration up to 1 !M TaXPD (Supple-
mentary Figure S9A). The time courses displayed clear lag
phases, which suggests that TaXPD may proceed through
multiple repeated steps to fully unwind the duplex DNA,
as observed for other helicases (42). The intra-molecular
crosslinked mutants, 100C-238C and 107C-312C, showed
a large reduction (but not abolition) of the helicase activity
(Figure 5C and Supplementary Figure S9A). The decrease
in the helicase activity of 100C-238C appeared proportional
with the degree of crosslinking (Figure 5C). Both biotin-
modified DNA and neutravidin biotin-DNA (which is too
big to pass through any conceivable pore) complex behaved
normally in the helicase assay, ruling out DNA threading as
a model (Supplementary Figure S9B).
DISCUSSION
Studies of the archaeal XPD helicases have yielded a num-
ber of significant insights relevant to this important fam-
ily of DNA repair enzymes. These have included the iden-
tification of the essential 4FeS cluster (15), structural and
biochemical studies of archaeal XPDs that explained the
molecular basis for disease causing mutations in humans
(12–14,19), single-molecule studies of XPDmechanism (re-
viewed in (43)), the investigation of DNA damage detec-
tion (44–46) and the possibility of CT from the 4FeS cluster
to DNA (reviewed in (47)). Nonetheless, the mechanism of
XPD helicase, including such fundamental aspects as the
precise path that the DNA adopts, is still not fully under-
stood. It is presumed that the translocated strand passes
through a central pore formed by the HD1, 4FeS and Arch
domains. Yet all structures show that these domains make
a number of polar and hydrophobic interactions that hold
together the domains.Moreover, a spin labelling/PELDOR
study of TaXPD yielded no evidence for opening at the in-
terface between the Arch and 4FeS domain (48). Since XPD
binds ssDNA within a repair bubble without a free DNA
end, either the protein has to undergo a large conforma-
tional change separating the two domains or the DNA does
not pass through the pore. Since no structure exists of a
complex with a DNA fork, it is at least theoretically pos-
sible that the path of the translocated DNA beyond HD2 is
non-canonical in this class of helicases.
Remarkably the structure of SaXPD with HD2 miss-
ing adopts the same closed state as the full-length protein,
consistent with its stability, recently highlighted by spin la-
belling and mutational analysis of residues at this interface
in TaXPD (48). Moreover, it was previously shown (12,13)
that the conformation of the Arch domain was not affected
by the 4FeS domain being disordered and thus by the dis-
rupted interface between the two (PDB IDs: 3CRW and
2VL7). In contrast, the integrity of the FeS cluster/domain
is greatly affected when not stabilized by the contact with
the Arch domain (48). Overall, the data indicate a highly
stable closed conformation of the pore.
Crystallizing protein–DNA complexes is often challeng-
ing due to low affinity or dynamic nature of the complexes.
In some cases, this has been successfully overcome by cova-
lently crosslinking internal sites of the DNA to the protein
(37–41). Here we have presented a similar approach applied
to the TaXPD helicase, but crosslinking the 5′-end instead
of internal sites of DNA. The covalent TaXPD–DNA com-
plex agrees with the previous reported TaXPD–DNA struc-
ture (19), in that it shows the strand bound to the HD2 do-
main. The Fo-Fc electron density permits the experimental
positioning of an additional 3′ nucleotide compared to the
previous study. We emphasize that the crosslinked protein
was used only for structural studies not for functional ones.
The data show degradation of the remaining bases in our
system rather than disorder, whether this occurs in other
systems is not known. Although a hairpin DNA was stable
against nuclease cleavage we were unable to obtains crystals
of the complex.
We observed a conformational change in loop 422–428
that allows Y425 to stack against the base in a '–' in-
teraction not seen previously. Mutation of this conserved
residue had been shown to result in decreasedDNA affinity,
helicase and ATPase activity (19). The corresponding loop
in S. acidocaldarius and S. tokodaii XPD is already in the
right conformation for DNA binding and the role of Y425
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Table 2. Effect of pore crosslinking on DNA binding and ATPase activity of TaXPD
Varianta KD1 (!M) KD2 (!M)
ATPase activity (mol
ATP*min−1*mol−1 XPD)
100–238 NC 0.4 ± 0.1 0.5 ± 0.1 17.4 ± 0.5
100–238 C 0.6 ± 0.1 0.5 ± 0.1 5.2 ± 1.5
107–312 NC 0.3 ± 0.05 0.4 ± 0.05 21.1 ± 0.8
107–312 C 0.3 ± 0.1 0.4 ± 0.05 11.5 ± 1.9
aNC: non-crosslinked; C: crosslinked (91% for 100–238 and 83% for 107–312); KD1, KD2: dissociation constants of TaXPD–DNA in the absence and
presence of AMPPNP, respectively.
is probably accomplished by Y370 and R363, respectively,
according to the structures. In human XPD, the equivalent
of Y425 is F508, with probably similar structural function.
R529 from HD2 and E354 from the Arch domain interact
with the additional guanine base of DNA in our structure
(Figure 4D). The corresponding residue of R529 in human
XPD is Y527, which is probably also involved in stabilizing
DNA bases.
We show here for the first time that locking the Arch
and 4FeS domains in the closed state through covalent
crosslinking inactivates the TaXPD helicase activity (Fig-
ure 5C and Supplementary Figure S9A), although theDNA
binding is unaffected (Figure 5A, Table 2) and the AT-
Pase activity (Figure 5B, Table 2) is only reduced. We took
care to control for residual helicase activity arising from
non-crosslinked protein and made two different crosslinked
variants. The preservation (albeit reduced) of ATPase ac-
tivity shows that the crosslink has not grossly altered the
protein structure. The conservation of DNA binding affin-
ity is consistent with an essentially native structure for the
crosslinked protein but also suggests that DNA makes few
additional interactions (or only very weak ones) inside and
at the other side of the pore region, correlating with the
structural data. We used biotin-modified DNA analogues
to rule out threading of DNA through the pore. The in-
activity of the crosslinked proteins in the helicase assay is
due to their inability to undergo the conformational change
necessary to translocate DNA (DNA binding and ATP hy-
drolysis remain intact). These data represent strong experi-
mental evidence thatDNA is translocated through the pore,
following an initial binding event that involves stable inter-
actions of ssDNA with the HD2 domain, probably whilst
the pore is conformationally closed (Figure 6), as proposed
previously (21). Subsequently, transient opening of the in-
terface between the Arch and 4FeS domains allows access
to the pore and the secondary binding site along the top of
the HD1 domain, as observed in other superfamily 2 heli-
cases (49).
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